More than 1.1 million cases of prostate cancer were recorded in 2012, accounting for around 8 per cent of all new cancer cases and 15 per cent in men.
Age-adjusted incidence rates of prostate cancer have increased dramatically and this is largely because of the increased availability of screening for prostate-specific antigen (PSA) in men without symptoms of the disease. This test leads to detection of many prostate cancers that are small and/or would otherwise remain unrecognised, and which may or may not develop further into higher stage disease.
The Continuous Update Project Panel made the following judgements; greater body fatness is probably a cause of advanced prostate cancer, and developmental factors (marked by adult attained height) are probably a cause of prostate cancer.
The countries with the top 20 highest incidence of prostate cancer in 2012 are given in the table below.
Martinique had the highest rate of prostate cancer, followed by Norway and France.
About 68 per cent of prostate cancer cases occurred in more developed countries.
The highest incidence of prostate cancer was in Oceania and Northern America; and the lowest incidence in Asia and Africa.
Age-Standardised Rate per 100,000 (World)
Trinidad and Tobago
United States of America
Source: Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2014. Available from: http://globocan.iarc.fr, accessed on 16/01/2015.